Table 1.

Patient and Disease Characteristics

	UD (%)	RD (%)	Haplo (%)	p value
N	43	32	24
Age, years				0.09
Median	55	60	54
Range	23–73	32–72	21–73
Karnofsky Performance Scale				0.85
100	0 (0)	2 (6)	2 (8)
90	12 (28)	9 (28)	6 (25)
80	18 (42)	14 (44)	9 (38)
<70	13 (30)	7 (22)	7 (29)
HCT-CI Risk				0.70
0	5 (12)	4 (13)	1 (4)
1 –2	5 (12)	5 (16)	2 (8)
≥3	33 (77)	23 (72)	21 (88)
ELN Risk				0.83
High	17 (40)	13 (41)	12 (50)
Intermediate	24 (56)	17 (53)	10 (42)
Low	2 (4)	2 (6)	2 (8)
Disease Etiology				0.27
De Novo	22 (51)	20 (63)	17 (71)
Secondary	21 (49)	12 (38)	7 (29)
Disease Status at Transplant				0.99
Primary Induction Failure	22 (51)	18 (56)	12 (50)
Relapse Refractory	21 (49)	14 (44)	12 (50)
Active Disease Subtype				0.88
Morphology	37 (86)	24 (75)	20 (83)
Cytogenetics	6 (15)	6 (18)	4 (17)
Extramedullary Disease	0 (0)	2 (6)	0 (0)
Median Relapse to Transplant, months	4	2	6	0.24
Median Duration of CR1, months	4	3	5	0.34
Median Pre-Transplant Blast% in BM	18 (0–72)	9 (0–87)	19.5 (0–84)	0.13
Median Pre-Transplant Blast% in blood	5 (0–32)	4 (0–72)	7 (0–60)	0.87

Abbreviations: CR1: first complete remission; BM: bone marrow